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Cytokines that are secreted as a response to viral antigen not only have direct antiviral properties but also crucially
influence immune reactions determining the outcome of infection. As an advantageous alternative to the study of cytokines
present in the supernatants of antigen-specific T cell clones and lines, we have used ELISPOT assays to determine the
number of interferon-g (IFN-g)- and IL4-producing cells generated by peripheral blood mononuclear cells from patients with
acute hepatitis B (AHB) and chronic hepatitis B (CHB) infection in response to HBcAg in a short-term culture (48 h). In
response to HBcAg IFN-g was predominantly produced. In contrast to the results obtained in acute hepatitis B, the typical
lymphokine pattern in CHB was characterized by a weak or absent antigen-specific IFN-g production. A predominance of
IL-4-producing cells was not observed in either AHB or CHB. A significant number of IFN-g-producing cells was usually
detectable during phases of viral elimination and the quality of the lymphokine response seemed to be epitope independent.
Comparison of the results obtained in proliferation assays and ELISPOT assays clearly shows that lymphokine production
upon stimulation with viral protein is totally independent of T cell proliferation and more sensitively reflects antiviral reactivity.
© 1999 Academic Press
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A vigorous, polyclonal, and multispecific cytotoxic and
elper T cell response to the hepatitis B virus is readily
etectable in the peripheral blood of patients with acute
epatitis B but is weak or undetectable in patients with
hronic infection. This T cell response is believed to be
esponsible for the elimination or control of the hepatitis
virus (Ferrari et al., 1991; Guidotti et al., 1994; Jung et al.,
995; Nayersina et al., 1991; Rehermann et al., 1995; Tsai
t al., 1992). The importance of a HLA class II restricted
helper cell response is further supported by the asso-
iation between the HLA DRB1 allele 1302 and self-
imited acute hepatitis B (Thursz et al., 1995). CD41 T
elper cells exert their function via lymphokines. Accord-
ng to their lymphokine pattern they have been classified
nto Th1 and Th2 subsets, where interferon-g (IFN-g),
L-2 and TNF represent the Th1-type response, which
timulates cellular immune reactions, and IL-4, IL-5, IL-6,
nd IL-10 are lymphokines of the Th2-type response,
hich supports B cell development and enhances anti-
ody production. The question of preferential induction
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 149 89 70956181. E-mail: Maria-Christina.Jung@med.2.Ied.uni-muenchen.de.
165f either T cell subset in HBV infection has not been
xtensively examined. Cellular immune responses seem
o prevail in acute hepatitis (Jung et al., 1991), whereas
hronically infected patients demonstrate significantly
reater antibody responses. Studies in mice suggest that
he preferential recognition of hepatitis B nucleocapsid
ntigens by Th1 or Th2 cells is epitope and MHC depen-
ent (Milich et al., 1995). Elegant experiments in trans-
enic mice have revealed the superior role of IFN-g and
NF in the antiviral T cell response to HBV (Guidotti et al.,
994, 1996) and studies in human demonstrate a pre-
ominance of Th0 in the liver and of Th1 cells in the
eripheral blood (Bertoletti et al., 1997; Penna et al.,
997). The techniques used so far in human do not allow
quantitative analysis of lymphokine-producing cells. In
ddition the cytokine profile of T cell clones and cell lines
ay not be representative due to the influence of long-
erm culture, and the measurement of cytokines in su-
ernatants may be hampered by the binding of cytokines
o cell-bound or soluble receptors (Engelberts et al.,
991).
The ELISPOT assay used in the present paper has
mportant advantages, which contribute to a more com-
lete and perhaps biologically more relevant picture of
he antiviral cellular immune response in HBV infection:
n the first place it allows quantitative assessment of
0042-6822/99 $30.00
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166 JUNG ET AL.ytokine-producing cells in response to virus-specific
ntigen. This determination can be performed in a short-
erm culture, which excludes the disadvantages of T cell
ines and T cell clones. The test can be carried out with
elatively low numbers of cells. It does not concentrate
xclusively on T cells. Comparison between cytokine
roduction and T cell proliferation could show whether T
ell proliferation is accompanied by cytokine production
nd whether cellular antiviral “nonresponsiveness” in
hronically infected individuals is confined to T cell pro-
iferation. The most important advantage of this approach
s the proximity to the biological situation with respect to
he frequency of lymphokine-producing cells in different
ell populations after a short-term culture with viral an-
igens.
The results of these studies should therefore help to
nswer the following questions: (a) Which is the predom-
nant cytokine produced as a response to hepatitis B
ore antigen (HBcAg)? (b) Is there a difference in cyto-
ine production between patients with self-limited infec-
ion and those with chronic infection? (c) Compared to
he conventional [H3]thymidine uptake assay, is the ELIS-
OT assay superior in reflecting cellular antiviral activity?
RESULTS
umber of cells producing IFN-g and IL-4 in
esponse to HBcAg and phytohemagglutin (PHA) in
atients with acute and chronic hepatitis B
The number of IFN-g- and IL-4-producing cells in re-
ponse to HBcAg and PHA was estimated in acutely
nfected (n 5 51) and chronically infected patients (n 5
9). PHA was used as a positive control. All patients
5
FIG. 1. The median number of IFN-g spots/200,000 PBMC in response
(AHB, n 5 51) and chronic hepatitis B (CHB, n 5 59). Solid spots i
ubtracting the background medians. Each spot represents the responroduced IL-4 (mean number of spots/2 3 10 cells, t2.75 6 54.97 SEM, n 5 61) and IFN-g (mean number of
pots/2 3 105 cells 309.90 6 151.12 SEM, n 5 110) in
esponse to PHA. As expected the number of lympho-
ine-producing cells was much lower in response to
pecific antigens.
As can be seen in Fig. 1 the majority of patients with
cute hepatitis B (60.78% 5 31/51 patients) showed a
ignificant number of IFN-g-producing cells in response
o HBcAg (mean number of spots/2 3 105 cells 6 SEM,
8.25 6 35.27), whereas only 25.42% (15/59) of the chron-
cally infected patients responded to the viral antigen
mean number of sponts/2 3 105 cells 6 SEM 10.03 6
7.05) (P # 0.0002). In only a few chronically infected
atients did the number of lymphokine-producing cells
each the level obtained in patients with acute hepatitis
infection. To evaluate a possible correlation between
he number of positive cells in the ELISPOT assay and
ransaminases we calculated the Pearson correlation
oefficient. Neither in chronically infected patients (R 5
.03) nor in acutely infected patients (R 5 0.06) could we
emonstrate a correlation between these parameters
Table 1).
In contrast IL-4-secreting cells in response to HBcAg
ould not be detected in either patients with acute hep-
titis (n 5 27) or those with chronic hepatitis (n 5 34).
hat the absence of IL-4 production cannot be explained
y the technique used is shown by stimulation of PBMC
f acute hepatitis B (AHB) (n 5 10) and chronic hepatitis
(CHB) (n 5 13) with tetanus toxoid (TT), which is known
o be a potent inductor of IL-4 (Fig. 2).
Peripheral blood mononuclear cells (PBMC) from both
atient groups are able to produce IL-4 in response to
his antigen (TT). Three of ten patients with acute hepa-
in vitro challenge with HBcAg (1 mg/ml) in patients with acute hepatitis
a significant response. The median values have been corrected by
ne patient.to an
ndicateitis and 3/13 patients with chronic hepatitis demon-
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167VIRUS-SPECIFIC CYTOKINE INDUCTION IN HEPATITIS B INFECTIONtrated IL-4-producing cells in response to tetanus tox-
id. IL-4 production in response to HBcAg stimulation
as absent, whereas the peripheral blood mononuclear
ells showed a significant number of IFN-g-producing
ells in response to HBcAg in the same experiment.
inetics of HBcAg induced IFN-g-producing cells
n acute and chronic hepatitis B infection
HBcAg-specific T cell activation was shown to be
ssociated with viral clearance (Jung et al., 1995). How-
ver, the cytokine profile of unselected PBMC in the
ourse of resolving hepatitis has not yet been described.
n the other hand, chronic hepatitis B has been sug-
ested to be associated with an absence of a Th1- or the
redominance of a Th2-like lymphokine profile. To ex-
lude the possibility that lymphokine determinations at
ingle time points did not adequately reflect the spec-
TABLE 1
Correlation of ALT Values and Significant ELISPOT Results in 31
atients with Acute Hepatitis B (AHB) and 15 Patients with Chronic
epatitis B (CHB)
AHB CHB
Number of
interferon-g spots ALT (U/l)
Number of
interferon-g spots ALT (U/l)
12 306 12.5 59
23.5 870 17 78
12 245 63 45
15 320 43 65
20.5 98 57 54
17 280 41.5 52
16 1940 40 43
33 1045 10.5 35
14 927 11.5 76
98 250 10.5 42
56 13 28.5 34
85 765 78 56
29.5 582 14 35
25 786 45 33
18.5 610 11 87
33 444
4.5 1360
50 271
108.5 1168
17.5 253
127 85
136 79
20.5 520
28.5 906
122 127
11 381
44.5 69
21 591
14 580
85 825
43.5 1180rum of lymphokines produced during the entire course Pf the disease, we prospectively and serially at various
ime points determined the lymphokine profile of patients
uring infection. Representative results for acute infec-
ion are shown in Fig. 3. In acute self-limiting hepatitis, a
ignificant number of IFN-g-producing cells are readily
etectable during the acute phase of infection and this
umber declines after viral elimination. A significant
umber of IL-4-producing cells were not detectable. The
LISPOT assay more frequently gave significant positive
esults than the T cell proliferation assay (Fig. 3).
Long-term observation of cytokine-producing cells and
f T cell proliferation in response to HBcAg in chronic
epatitis B infection has been done in patients undergo-
ng antiviral treatment with famciclovir and lamivudine
Fig. 4). A response was characterized by an increase of
FN-g-producing cells when the HBV DNA level declined
r became negative. Again, the detection of interferon-
-producing cells was more frequent than T cell prolif-
ration. The cytokine profile of chronically infected pa-
ients was not dominated by Th2 lymphokines as re-
lected by the absence of IL-4-producing cells (data not
hown).
ymphokine response to HBcAg/HBeAg peptides:
pitope dependency of the lymphokine response
Since it has been suggested that the pattern of lym-
hokine response is epitope dependent (Milich et al.,
995), we did ELISPOT assays using overlapping HBcAg/
BeAg derived peptides covering the entire HBc protein
n PBMC from 46 patients with acute hepatitis and from
8 patients with chronic hepatitis. We determined the
ind of lymphokines produced as well as the distribution
f the inducing epitopes within the HBcAg/HBeAg. Ten
atients with acute hepatitis and 16 patients with chronic
epatitis did not respond to either peptide, which con-
irms the specificity of the response (data not shown). In
ontrast, 38 patients with acute hepatitis and 12 patients
ith chronic hepatitis showed a positive reaction to at
east one of the peptides and to nucleocapsid protein as
positive control. Stimulation of PBMC with HBcAg de-
ived peptides led exclusively to IFN-g production. In
ontrast to the data obtained in mice (Milich et al., 1995)
L-4 production could not be induced by any epitope
data not shown).
As shown in Fig. 5 IFN-g was inducible in both patient
roups by almost all peptides used. Epitope mapping
ith the ELISPOT assay in acute hepatitis showed that
mino acids (aa) 61–85 most frequently induced IFN-g
roduction (44.12% of the patients). Other immunogenic
equences could be identified in the amino-terminal part
f the protein, aa 1–25 (33.33%) and aa 21–45, (13.88%)
nd in the carboxy-terminal part, aa 81–105 (36.11%) and
a 121–145 (19.44%). All peptides were immunogenic for
BMC of both acutely and chronically infected patients.
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168 JUNG ET AL.xcept for aa 161–183 and a part of aa 141–165 all
pitopes described are shared by HBcAg and HBeAg.
omparison of the results in proliferation
nd ELISPOT assays
To answer the question whether proliferation and
LISPOT assays record similar cellular activities, we
FIG. 2. Number of IL-4-producing cells in three patients with acute an
rotein of HBV (HBcAg). The mean of the crude data is presented.
FIG. 3. Determination of IFN-g-producing cells and T cell proliferat
epatitis B infection in three patients. Black columns represent signific
pots and represent the mean of duplicates. In patient 1 HBsAg disapp
994, and patient 3 lost HBsAg at the end of August 1995.ompared the results of the two assays in 51 patients
ith acute hepatitis B and 56 patients with chronic hep-
titis. Using the Pearson correlation method and a linear
egression analysis, no correlation between the results
btained in the two assays could be demonstrated (R2 5
.019 in acute hepatitis, R 5 0.0031 in chronic hepatitis B)
Fig. 6).
nic hepatitis B in response to tetanus toxoid (TT) and the nucleocapsid
) upon stimulation with HBcAg (1 mg/ml) during the course of acute
lues. The results have been corrected by subtracting the background
n November 1995, patient 2 lost HBsAg at the beginning of Decemberd chroion (SI
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169VIRUS-SPECIFIC CYTOKINE INDUCTION IN HEPATITIS B INFECTIONComparison of significant positive test results showed
hat in acute hepatitis B the ELISPOT assays gave sig-
ificant results in 60.78% of the patients, whereas the
roliferation assay was positive in only 29.41%. In
hronic hepatitis B infection a significant antigen-spe-
ific IFN-g production was detectable in 25.41% of the
atients and a significant specific cell proliferation in
7.86%. These data show that the ELISPOT assay is more
ensitive in detecting antiviral cellular activity.
DISCUSSION
There are several lines of evidence showing that cy-
okines that are secreted as a response to viral antigens
ontrol immune reactions determining the outcome of
nfection. In the present study, peripheral blood mononu-
lear cells from patients with acute or chronic hepatitis B
nfection were stimulated with viral antigen and tested
or T cell proliferation and for cytokine production (IFN-g,
L-4) in an ELISPOT assay.
We have chosen to use ELISPOT assays to study, at
he protein level, local cytokine production rather than
ulk-release detection methods for several reasons.
irst, relatively few cells are necessary to perform the
LISPOT assay, and in situations where few producing
ells were present, this assay allows the detection of
ells secreting a given cytokine. In contrast, ELISA as-
ays are not sufficiently sensitive for the detection of the
ytokine in the corresponding cell culture supernatant.
FIG. 4. Determination of IFN-g-producing cells and T cell prolifera-
ion (SI) upon stimulation with HBcAg (1 mg/ml) during the course of
hronic hepatitis B infection in one patient undergoing famciclovir and
amivudine treatment. Dark columns represent significant values. The
esults have been corrected by subtracting the background spots and
re presented as means.econd, the short incubation times necessary to perform 0he ELISPOT assay allow one to obtain a cytokine snap-
hot of a given pathological sample. This is likely to
inimize antagonistic or synergistic cytokine interac-
ions that occur during the prolonged cultures that ELISA
eterminations require. Third, the ELISPOT assay allows
etermination of the frequency of cytokine-producing
ells. Finally, this method allows the detection of the
rotein released into the extracellular environment and
herefore adds important information when compared
ith techniques measuring cytokine mRNA levels.
FIG. 5. Production of IFN-g in patients with acute (n 5 36) and
hronic (n 5 12) hepatitis B infection in response to HBcAg derived
eptides. The figure shows the percentage of patients responding
ignificantly to stimulation with HBcAg derived peptides.
FIG. 6. Analysis of interferon-g-producing cells and T cell prolifera-
ion in acute (n 5 51 patients) and chronic hepatitis B (n 5 56 patients)
sing the Pearson correlation method. Results are demonstrated in a
inear regression analysis. No correlation could be demonstrated (R2 5
.019 in acute hepatitis B, R 5 0.0031 in chronic hepatitis B).
w
l
d
l
w
T
p
a
w
c
e
t
c
d
e
a
H
c
d
a
h
i
c
s
a
I
H
b
a
c
e
b
t
i
h
c
t
h
q
m
c
a
c
a
a
f
c
t
m
c
s
b
n
t
t
i
d
p
I
c
q
t
c
a
i
c
a
c
r
a
a
e
s
p
a
c
t
a
m
r
l
l
a
p
[
p
h
t
s
a
G
p
a
c
t
d
(
t
p
170 JUNG ET AL.When peripheral blood mononuclear cells of patients
ith acute or chronic hepatitis B infection were stimu-
ated with PHA IFN-g and IL-4 production could be easily
etected although the number of IL-4-secreting cells was
ower than the number of IFN-g-producing cells.
In response to HBcAg, IFN-g but not (number of cells
as not significant) IL-4 was produced, indicative of a
h1-type response and in agreement with what has been
ublished by others using HBcAg-specific T cell lines
nd clones (Penna et al., 1997). Although the studies
ere done with unselected polyclonal cells, we saw a
learer picture in terms of lymphokine profile than Penna
t al. (1997), who showed IFN-g production in combina-
ion with IL-4 and/or IL-5 production in 5/15 polyclonal T
ell lines. These differences might be explained by the
ifferent techniques used (ELISA versus ELISPOT). How-
ver, our failure to detect IL-4-secreting cells in acutely
nd chronically infected patients upon stimulation with
BcAg is not likely to be explained by experimental
onditions (i.e., sensitivity of the test) because IL-4-pro-
ucing cells were detectable upon stimulation with PHA
nd with TT (Fig. 3).
The kind of lymphokine profile detected in chronic
epatitis B infection did not differ from acute hepatitis B
nfection. The preferential activation of IFN-g-producing
ells was not HBcAg epitope dependent as could be
hown in this study by using HBcAg derived peptides in
n ELISPOT assay. As in acute self-limited hepatitis,
FN-g is also the lymphokine produced in response to
BcAg in chronic hepatitis. This cytokine pattern has
een confirmed by the data of Bertoletti et al. (1997), who
nalyzed 291 clones derived from six patients with
hronic hepatitis B and demonstrated a Th1 profile. How-
ver, the data published so far allow only a comparison
etween intrahepatic clones of chronically infected pa-
ients and peripheral T cell clones and lines of acutely
nfected individuals. In contrast, in the study presented
ere, we were able to directly compare the same cell
ompartment within the two patient groups.
The cytokine response in chronic hepatitis differs from
hat in acute hepatitis in that the response in acute
epatitis is significantly more vigorous and more fre-
uently detectable. Patients with acute hepatitis typically
ount a significant IFN-g response during the entire
ourse of infection and lymphokine production declines
fter viral elimination. The typical lymphokine pattern in
hronic hepatitis B is characterized by a weak or absent
ntigen-specific IFN-g production.
In contrast, chronically infected patients responding to
ntiviral treatment with reduction of HBV DNA (inter-
eron-a lamivudine, famciclovir) show a transient in-
rease of IFN-g-producing cells. Although it is believed
hat liver damage reflected by elevated transaminases is
ediated by functionally active virus-specific lympho-
ytes no correlation was found between significant re-
ults in the ELISPOT assay and transaminases. This may oe explained by the fact that peripheral lymphocytes do
ot necessarily simultaneously reflect T cell activity in
he liver and detection of virus-specific lymphocytes in
he periphery possibly indicates virus-specific cells com-
ng from or going into the liver.
The ELISPOT assay provides a powerful means to
etect and enumerate cells on the basis of their cytokine
roduction. This was a prerequisite to detect the few
FN-g-producing cells typical for many patients with
hronic hepatitis and to compare the precursor cell fre-
uencies between the two patient groups. In addition to
he determination of the frequency of cytokine-producing
ells and the kind of lymphokine produced, the ELISPOT
ssay seems to be an important tool to assess antiviral
mmune responses. Thus far measurement of T helper
ell activity has been confined to T cell proliferation
ssays. Comparison between proliferation and ELISPOT
ytokine production shows no correlation between the
esults of the two test systems. A significant number of
cutely infected patients responded to viral antigen with
significant IFN-g production, but with no T cell prolif-
ration. On the other hand only a few patients demon-
trated a significant T cell proliferation without cytokine
roduction. These data may indicate that the ELISPOT
ssay measures cytokine production by several different
ell populations responding to viral antigens, whereas
he T cell proliferation assay reflects predominantly the
ctivity of CD41 T cells. Alternatively, the ELISPOT assay
ay assess a quality of CD41 T lymphocytes that is not
eflected by T cell proliferation.
The quantitation of lymphokine-producing cells is
ikely to more precisely and sensitively reflect the bio-
ogical situation during an antiviral immune response in
cute and chronic hepatitis B infection and thus com-
lete the data obtained with the conventional
H3]thymidine uptake assay.
MATERIALS AND METHODS
Patients. Fifty-one patients with acute hepatitis and 59
atients with chronic hepatitis B were studied. Acute
epatitis was diagnosed on the basis of elevated amino-
ransferases, positive hepatitis B surface antigen (HB-
Ag), HBV DNA, and anti-HBc immunoglobulin M (IgM)
s determined by kits obtained from Abbott (Wiesbaden,
ermany). All patients with chronic hepatitis B were
ositive for HBsAg and HBV DNA for more than 6 months
nd the diagnosis was proven histologically.
Isolation of PBMC. Human peripheral blood mononu-
lear cells were isolated from heparinized blood ob-
ained from patients with AHB and CHB by Ficoll-paque
ensity gradient centrifugation as described elsewhere
Perlmann et al., 1976). The PBMC were washed four
imes in phosphate-buffered saline (PBS) and resus-
ended in tissue culture medium (RPMI 1640 medium,
btained from Gibco, Grand Island, NY) containing 2 mM
Lp
h
o
f
H
l
t
2
1
(
9
o
G
U
d
M
p
a
o
a
h
f
T
m
P
d
P
i
a
t
o
e
a
t
s
U
w
t
a
s
n
w
w
w
(
m
m
w
m
c
G
t
d
s
t
p
t
p
A
e
(
t
1
y
s
t
p
b
m
I
n
I
d
s
b
s
t
E
m
y
F
a
B
E
E
F
171VIRUS-SPECIFIC CYTOKINE INDUCTION IN HEPATITIS B INFECTION-glutamine, 1 mM sodium pyruvate, 100 U of penicillin
er milliliter 100 mg of streptomycin per milliliter and 10%
uman AB serum.
Recombinant proteins, synthetic peptides, tetanus tox-
id, PPD, and mitogen. Recombinant HBcAg obtained
rom bacterial extracts of Escherichia coli K-12 strain
B101 was purchased from Biogen (Geneva, Switzer-
and) (Pasek et al., 1979). Nine overlapping 25-mer pep-
ides covering the entire HBV core sequence (aa 1–25,
1–45, 41–65, 61–85, 81–105, 101–125, 121–145, 141–165,
61–183) were synthesized by Multiple Peptide Systems
San Diego, CA). All peptides were purified to more than
5% by high-pressure liquid chromatography.
Tetanus toxoid and PPD were used at a concentration
f 10 mg/ml and obtained from Behring-Werke (Marburg,
ermany). PHA (HA 16; Murex Diagnostics, Dartford,
nited Kingdom) was used at a concentration of 5 mg/ml.
ELISPOT assay. The ELISPOT assay was performed as
escribed elsewhere (El Ghazali et al., 1993). Briefly,
illititer HA nitrocellulose-bottom 96-well plates (Milli-
ore Co., Bedford, MA) were coated with 100 ml of the
ppropriate mAb (anti-IFN-g, anti-IL-4) at a concentration
f 15 mg/ml in PBS and incubated overnight at 4°C. All
ntibodies were purchased from Mabtech AB (Stock-
olm, Sweden). Unbound antibodies were removed by
our successive washings with PBS containing 0.05%
ween. The coated wells were filled in duplicate with 100
l of RPMI medium containing 200,000 freshly isolated
BMC together with antigen [HBcAg (2 mg/ml), HBcAg-
erived peptides (10 mg/ml, tetanus toxoid (10 mg/ml),
PD (10 mg/ml)] or PHA (5 mg/ml) as positive control and
ncubated undisturbed for 48 h at 37°C in a humidified
tmosphere with 5% CO2.
After incubation the cells were removed by washing
he plates four times with PBS. One hundred microliters
f the biotin-conjugated mAb (Mabtech) was added to
ach well at a dilution of 1 mg/ml and incubated for 4 h
t room temperature. Then the plates were rinsed four
imes by immersion in PBS and exposed to 100 ml
treptavidin–alkaline phosphatase (Mabtech AB) for 1 h.
nbound conjugate was removed by washing thoroughly
ith PBS and finally 100 ml of BCIP/NBT substrate solu-
ion (Bio-Rad Laboratories, Richmond, CA) was added
nd the reactions were stopped. The color reaction was
topped after 60 min by extensive washing under run-
ing water and after drying, the number of blue spots
as scored using a dissection microscope. Stimulation
ith PHA was used as a positive control.
PBMC proliferation assay. PBMC (1 3 105 per well)
ere incubated in 96-well U-bottom plates from Costar
Cambridge, MA) for 5 days in the presence of HBcAg (1
g/ml), peptides (10 mg/ml), TT (10 mg/ml), or pHA (5
g/ml) in 150 of RPMI 1640 medium. The cell cultures
ere labeled by incubation for 16 h with 2 mCi of [3H]thy-
idine (sp act 80 mCi/mmol; Amersham). The cells wereollected and washed on filters from Dunn (Asbach,ermany) with a cell harvester (Skatron, Sterling, VA) and
he amount of radioactivity incorporated into DNA was
etermined using a beta counter (LKB/Pharmacia, Upp-
ala, Sweden). Triplicate cultures were assayed rou-
inely, and the results were expressed in mean counts
er minute. The stimulation index (SI) was calculated as
he ratio between the counts per minute obtained in the
resence of antigen and those obtained without antigen.
n SI of .3 was considered significant. By separation
xperiments and fluorescence-activated cell sorter
FACS) analysis, it could be demonstrated that prolifera-
ion was confined to the CD41 T cell subset (Jung et al.,
991).
Statistical analysis. For the purpose of statistical anal-
sis the results are shown as specific spots (number of
pots in the presence of HBcAg or HBcAg-derived pep-
ides minus the number of spots without the specific
rotein). A result was considered significant if the num-
er of specific spots minus spots in the control wells .
ean value 1 13 standard deviation (.10 spots for
FN-g, .1.5 for IL-4). All tests within the 90% interval for
egative controls (,20 spots for IFN-g, ,1.5 spots for
L-4) were considered for evaluation.
Analysis of the differences between the groups was
one using the x2 test. A P value ,0.05 was considered
tatistically significant. Analysis of significant differences
etween the two patients groups with regard to FACS
taining was done using the nonparametric Wilcoxon
est. A possible correlation between proliferation and
LISPOT was tested with the Pearson correlation
ethod and demonstrated with a linear regression anal-
sis.
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